Sentences with phrase «see changes in the program»

Democratic political strategist Hank Sheinkopf said the industry should expect to see changes in the program, but not big changes.

Not exact matches

The real significance of the Google Patent Starter Program is instead more subtle, and should be seen against the backdrop of other moves Google is undertaking to change the economic incentives that have made patents such a problem for the tech sector in the first place.

Many a desktop computer has been purchased specifically to take advantage of these programs, which allow even an unsophisticated computer user to change a few critical assumptions and, in the blink of an eye, recalculate an entire financial model (see «How VisiCalc Works,» INC., November 1981, page 104).

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

From what we see coming out of the top levels of China's leadership in the past few weeks, we should be reasonably encouraged that some of the targets of these complaints are programmed for change.

For more information on the standard SOMA securities lending program terms, please see: August 26, 1999 - Announcement of Change in Lending Limits for SOMA Securities Lending Program, September 7, 1999 - Revised SOMA Securities Lending Program — FAQs, and September 7, 1999 - Revised SOMA Securities Lending Program Terms and Condprogram terms, please see: August 26, 1999 - Announcement of Change in Lending Limits for SOMA Securities Lending Program, September 7, 1999 - Revised SOMA Securities Lending Program — FAQs, and September 7, 1999 - Revised SOMA Securities Lending Program Terms and CondProgram, September 7, 1999 - Revised SOMA Securities Lending Program — FAQs, and September 7, 1999 - Revised SOMA Securities Lending Program Terms and CondProgram — FAQs, and September 7, 1999 - Revised SOMA Securities Lending Program Terms and CondProgram Terms and Conditions.

The «one - off» buyback program shouldn't be seen as a change of position in the company's capital allocation plans, Thompson said.

1 See Osler Corporate Review dated June 2013 «Expansive Changes to Canada's Foreign Anti-Corruption Legislation Now in Force: Existing Compliance Programs Will Require Revisions»

Our Girls Learning Code program offer female - identified youth ages 3 - 12 hands - on experiences designed to inspire them to see technology in a whole new light — as a medium for self - expression, and as a means for changing the world.

I'm very pleased to see Canadian companies supporting employees during this time of change by investing in workplace training programs and committing to healthier workplaces.»

In 2017, the FITTskills international trade training program underwent a major update, including the addition of 60 % new content to reflect the changes we've seen in technology, ecommerce, trade agreements and morIn 2017, the FITTskills international trade training program underwent a major update, including the addition of 60 % new content to reflect the changes we've seen in technology, ecommerce, trade agreements and morin technology, ecommerce, trade agreements and more.

If you see your company vision wavering, you may consider introducing change programs that help your staff to live your vision and values in their everyday work.

As you can see in the 30 Day Change Review video below: On November 10th, 2014 Amanda Michelle was accepted into the 30 Day Change Program, with STUNNING Results:

And that camel - owner can bring all his camel - owning friends and they will give their tenth - plus offerings to The Church of the Great Needle and soon enough there will be a new building program to construct a fanstasmagoric «Golden Needle with Multiple Eyes» so that more camels can enter and then more camel - owners will come and soon there will be a vision for a bigger and better «Platinum Needle with Multiple, Rotating, Identity - Protected Eyes» and soon there will be a name change to «The Church of the Sharpest Needles in the Greatest Sewing Machine the World Has Ever Seen» and everyone shall stand amazed etc., etc., etc...; ^)

Obviously, legislators who study government programs observe society behaviors and see that changes have to be made in many government programs.

Already a movement is under way to improve end - of - life care by educating health - care providers to respond better to the needs of dying patients, by creating new care settings or improving existing ones, by seeking changes in methods of paying for appropriate care, by educating the public through conferences, town meetings, television programming, and even Web sites (see www.careproject.net), by providing adequate relief of pain, by withholding or withdrawing treatments that only prolong dying, by keeping company with those who are lonely, and by being a resource of meaning and hope for those tempted to despair.

The persuasiveness of religious programs toward change appear to be greatest when they are viewed by a person who is in a state of attitude imbalance or transition and seeking new forms of gratification for his or her needs; when they are viewed by a person for whom religious faith has always been a viable, if not vital, option; when the options being presented are seen as realistic and leading to a desirable end; when opportunity for demonstration exists in proximate distance to the viewing situation; and when the attitude or behavior is not central to the individual's self - concept and ego - functioning.

As can be seen, there has been a steady growth in the amount of time occupied by paid - time religious programs versus sustaining - time programs since 1959, with particularly rapid changes occurring from 1971 on.

«We are also going to introduce several areas where we feel we can take the predictability out of the audit, so instead of an auditor coming in and auditing the facility the same way, we'd like to see the auditors routine changed up to enhance the food safety program at the facility.»

In fact, you might see a change in your child's behavior almost immediately after you begin implementing the prograIn fact, you might see a change in your child's behavior almost immediately after you begin implementing the prograin your child's behavior almost immediately after you begin implementing the program.

-- In fact, many school nutrition directors have seen their school meal programs increase in participation since the initial changeIn fact, many school nutrition directors have seen their school meal programs increase in participation since the initial changein participation since the initial changes.

CPS sent a statement to the show noting recent changes to its food program, and Wu acknowledged that she did see a small increase in fruits and vegetables over the calendar year.

Do you see positive changes in your school's lunch program?

Beginning in 2017 you will begin to see changes to our website, printed materials and trainings, as well as references to our programs and members.

There are Mommy & Me Yoga programs, there's Parents Movie Morning, which is my personal favorite, there's a Parents Movie Morning at Hazard Center in San Diego and they show first - hand movies, which are shown with the lights raised in the movie theatre, the volume lowered, there's a changing table in the back, there's stroller parking and there are parents in the theatre that are there to see the movie.

When we change from traditional universal free breakfast to universal free classroom breakfast we see a 300 to 500 % increase in participation at that school because we have removed several barriers to participation including the stigma of the free and reduced meal program, students who arrive at school just before the bell or who would rather play and socialize during the traditional before school breakfast period.

I wish I found the actual political program to see the changes in various life aspects.

A ComRes poll for today's Independent has shown that 72 % of the public would like to see a change in the government's flagship austerity program.

Mujica says if a worker were to get a small raise each of the years, then by the time the payroll tax option is fully phased in, they might be earning the same amount of gross pay as when the program started, so would not see a change in their paychecks.

«These aren't pilot programs that help a lucky few; they are foundational changes that will lift up schools in every neighborhood,» said Mayor Bill de Blasio at the announcement, which can be seen in the video below.

C. Susan Weiler, a biogeochemist at Whitman College in Walla Walla, Washington, (and currently a program director at NSF) says recent years have seen «tremendous growth» in interdisciplinary collaboration among climate change scientists.

That change, combined with language protecting a research infrastructure program and graduate fellowships, would result in a combined 16 %, $ 255 million cut to the two directorates under attack — geosciences and the social and behavioral sciences (see chart).

I have a program where I invite philosophers to see what goes on in the lab, because it changes your intuition.

Russell Marx, director of Adolescent Eating Disorders Program at the University of California, San Diego, and chief science officer of the National Eating Disorders Association, expects to see big changes in diagnosis and treatment with the addition of binge eating disorder but less impact on anorexia diagnoses as the number of patients with ED - NOS is reduced.

Then, in September of 1999, we launched the new Gladstone Institutes Postdoctoral Training Program, incorporating many of the recommended changes (see sidebar) with a continuing commitment to improve stipends and benefits, mentoring, and career development.

A new study supported by the Milstein Medical Research Program at The Rockefeller University, however, has uncovered the molecular roots of skin discoloration that is often associated with psoriasis, suggesting the possibility of new treatments for pigmentation changes seen not only in psoriasis, but also in other conditions such as eczema and acne.

Stewart sees the PFF program as «a part of the culture» of the department, which, she says, is changing in a way that will benefit postdocs and new faculty members.

By measuring changes in the levels of proteins that control each cell death program and by observing the cells» physical changes, the team saw clearly that cocaine causes neuronal cell death through out - of - control autophagy.

At the same time, the rise in nondefense R&D is due entirely to the NIH increase, in a year when most other science and technology programs have seen only minimal funding changes from the prior year.

We hear from two people who work in new media at the BBC about how the advent of interactive content is changing the way the Corporation thinks about developing its new programming to really try to involve the viewer or listener in what they're seeing or hearing.

While representing a 6.3 percent cut below FY 2016 levels, it's something of a departure in a year that sees climate programs at EPA, NOAA, and elsewhere slated for much larger cuts, especially given White House Budget Director Mick Mulvaney's belief that dollars spent on climate change are a waste of money.

If you decide on beginning a weight training program, at first, you might not necessarily see changes in your body in the form of loss of fat, but you will gradually see yourself become more defined and slimmer overall.

Significant changes for individuals who finished the program were seen in areas like ADHD symptoms, attention, initiating tasks, organization and planning, and working memory.

It's not uncommon for you to start to see a reduction in your symptoms in the first week that you start the full program (diet, supplements, lifestyle changes).

All I can tell you is that if you commit to going 30 - days without any processed foods, sticking to real foods through the recipes and ideas in this program, you will see dramatic changes in your quality of life.

They will see a small change in their body fat, but like any other exercise program, if proper nutrition is not part of the plan the results will be disappointing.»

Furthermore, similar to mindset, if we don't address stress along side dietary changes in a comprehensive wellness program, it is almost impossible to see deep changes in our bodies and balance our hormones.

Click here and here to see why you should walk in nature and change your exercise program so that your HPA axis dysregulation doesn't continue to sap your energy and set you up for failure if you're using the wrong exercise program.

This is apparent in seeing the results of my patients who gradually change vs those in an immersion program like Dr. John McDougall's Whole Foods program or his 10 day program.

To see positive changes in your measurements is very encouraging and may be just what you need to propel yourself to the next phase of your lifestyle program.